Holly Welle

Doctor of Medicine,  Massachusetts General Hospital 

Location: India

Consulting Services

Legal Support Career Advice and Mentoring

Areas Of Interest

Molds, Cellular Slime CYP51 Enzymes Primase Ambrosia Cytochrome P-450 IIE1 Tree, Lapacho Glycosphingolipids Component, Tooth MAPK10 Mitogen-Activated Protein Kinase Cerebellar Nucleus, Deep Cytosol Aminopeptidase Reinforcement, Negative Abietane Diterpenes CD265 Antigen Heterogeneous Nuclear Ribonucleoprotein C Deficiency Disease, Lysine Alpha Ketoglutarate Reductase Receptors, Amino Acids Retroversions, Bone Status, Paternal Educational Kinetosome Dental Pulp Necroses Arginine Oxytocin

Professional Narrative

Dr. Holly Welle was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Welle has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Mayo Clinic 2008
Assistant Professor, Amgen 2004

Education

Doctor of medicine, Yale School of Medicine 2000
Doctor of osteopathic medicine, Yale School of Medicine 1987

Referees


Publications

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :